Proteomics

Dataset Information

0

Dissection of acetylomic profiles in T cell lymphoma following histone deacetylases inhibition


ABSTRACT: The aim was to dissect molecular changes in histone and non-histone protein acetylation dynamics following the genetic or pharmacological inhibition of HDAC activity in a model of Anaplastic Large Cell Lymphoma (ALCL), a T cell non-Hodgkin lymphoma, predominantly found in children and adolescents.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): T Cell

DISEASE(S): Lymphoma

SUBMITTER: Gabriela Lochmanova  

LAB HEAD: Zbynek Zdrahal

PROVIDER: PXD030503 | Pride | 2022-10-14

REPOSITORIES: Pride

altmetric image

Publications

Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma.

Zrimšek Maša M   Kuchaříková Hana H   Draganić Kristina K   Dobrovolná Pavlína P   Heiss Spornberger Verena V   Winkelmayer Lisa L   Hassler Melanie R MR   Lochmanová Gabriela G   Zdráhal Zbyněk Z   Egger Gerda G  

Cells 20220802 15


Histone deacetylases (HDACs) target acetylated lysine residues in histone and non-histone proteins. HDACs are implicated in the regulation of genomic stability, cell cycle, cell death and differentiation and thus critically involved in tumorigenesis. Further, HDACs regulate T-cell development and HDAC inhibitors (HDACis) have been approved for clinical use in some T-cell malignancies. Still, the exact targets and mechanisms of HDAC inhibition in cancer are understudied. We isolated tumor cell li  ...[more]

Similar Datasets

2021-06-14 | PXD019502 | Pride
2024-08-10 | PXD051761 | Pride
2024-08-10 | PXD046034 | Pride
2024-01-26 | PXD046788 | Pride
2018-09-20 | PXD010102 | Pride
2019-10-14 | PXD014739 | Pride
2021-09-15 | E-MTAB-9146 | biostudies-arrayexpress
2016-01-27 | PXD002537 | Pride
2023-04-04 | PXD039547 | Pride
2015-03-01 | E-GEOD-54344 | biostudies-arrayexpress